Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Total Non-Current Liabilities (2021)

Actinium Pharmaceuticals (ATNM) has disclosed Total Non-Current Liabilities for 1 consecutive years, with $5.8 million as the latest value for Q4 2021.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to $5.8 million in Q4 2021 year-over-year; TTM through Dec 2021 was $5.8 million, a N/A change, with the full-year FY2021 number at $5.8 million, changed N/A from a year prior.
  • Total Non-Current Liabilities was $5.8 million for Q4 2021 at Actinium Pharmaceuticals.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $5.8 million in Q4 2021 to a low of $5.8 million in Q4 2021.